It's been awhile since I saw the 595,400,675 OS number, which was exactly 5X higher than our current OS, leading me to conclude that management was going to declare a 5:1 forward stock split.
I think the stock split , in itself, would cause a short covering of shares that were sold, but not delivered. I don't think management is reporting Failures to Deliver yet. We did, however, see that they reported 229M shares in the float. That's 110M shares more than they issued.
Short sellers are going to be SOL, well beyond just getting margin calls, because I fully suspect management is going to recall all their loaned shares.
On top of that, the absolutely stellar performance of lenz in treating CMML, and covid, could result in regulatory authorizations and/or approvals, with the promise of even more good news in enhancing CAR-T safety and efficacy, and that could cause a stampede of buying interest.
I have historically pointed out supportive evidence for what I reported above. There are reasons for my claims.
News 
Market Data 
Discover 
